MedKitDoc, a German telemedicine platform, has raised 7 million euros in seed financing. In addition to Vorwerk Ventures, Acton Capital, and existing investor Picus Capital, FlixBus founders Daniel Krauss and Jochen Engert are also investing in the fast-growing digital health start-up based in Berlin and Hannoversch Münden.

Karmacist, the world’s first nutrigenomics-based wellness supplement, has closed a £700k pre-seed investment led by Founders Factory and travel entrepreneur Craig Burkinshaw, as it brings to market the world’s first wellness supplement that draws on the relationship between genetics and nutrients to support the growing numbers of consumers investing in their wellbeing. 

Glucose Republic (GR) has raised a £500,000 investment round from leading equity investors Deepbridge Capital and the Development Bank of Wales, to build the world’s first system focused on what  impact food has upon us.

Leading digital training solutions provider, WELL Training (WELL), has secured £625,000 funding from Midlands Engine Investment Fund (MEIF) West Midlands Equity Fund, managed by Midven, part of the Future Planet Capital Group, to drive its growth strategy in two main areas - increasing apprenticeship training capacity and expanding the use of its online digital training platform. 

NPIF - Maven Equity Finance, managed by Maven Capital Partners and part of the Northern Powerhouse Investment Fund (NPIF) has invested £500,000 in Advanced Bacterial Sciences Ltd, which creates, manufactures and sells biological solutions for a range of real-world pollution and maintenance problems. The funding will enable ABS to commercialise its portfolio of products, sell directly to end users, as well as invest in continuous product development, patenting future technologies and scientific advances.

Vinehealth has raised $5.5m in seed funding. The round was led by Talis Capital, with participation from previous investors Playfair Capital and Ascension. 

As the UK experiences record waiting times for diagnostic imaging, Digital Health startup, National MRI has raised $2.5m seed led by Oxford Capital, YZR, Founders Factory, KM Capital and well-known industry angels Tom Blomfield, Evelyne Bourke (ex-BUPA CEO) and Harry Hurst (PIPE CEO).

Neurovalens, a global leader in non-invasive neuro-technology, has secured new funding towards the development of mental health treatments that target Generalised Anxiety Disorder, Insomnia and Post Traumatic Stress Disorder (PTSD).

British Patient Capital has participated in Quell Therapeutics’ $156m Series B funding round. The deal is the first life sciences  investment from Future Fund: Breakthrough, a £375m programme where British Patient Capital co-invests with private sector investors in innovative R&D-intensive UK companies.

Award-winning medtech firm, Glyconics© has secured £1.5million in an Enterprise Investment Scheme (EIS) funding round ahead of a series A round next year. The innovative diagnostics startup, with offices in Cambridge, Norwich and Basingstoke, raised well over the intended £850k in a raise led by investment platform Wealth Club and existing investors, Deepbridge Capital and Boundary Capital. Demand from Wealth Club private investors and angel investors pushed the total amount further to £1.5 million.

Charco Neurotech, a medical technology company that develops solutions for people with Parkinson’s, has raised $10m seed investment round, co-led by technology investors Amadeus Capital Partners and Parkwalk Advisors, and joined by University of Tokyo Edge Capital Partners (UTEC), MINT Venture Partners, and existing investors, including Crista Galli Ventures. The financing is the largest European seed round in 2021 and the sixth largest globally for healthtech devices, according to Pitchbook.

Charco is a multi-award winning, Imperial College spinout. Its first therapeutic device, CUE1, provides life-changing neuromodulation therapy.

Gentronix, the UK-based contract research organisation (CRO) that is a leader in the field of genetic toxicology, has raised £700,000 in a funding round led by existing investor Mercia to support its continued growth.